The obesity pandemic continues to grow at an alarming rate. Because lifestyle modifications have been limited in their success in weight loss maintenance, pharmacotherapy plays an important role in achieving clinically significant weight loss and preventing the development or exacerbation of comorbid conditions. The plethora of on- and off-label AOM's(Anti obesity medication) creates the unique challenge for physicians to decide which medication may be most appropriate for the individual patient. Interestingly, Tirzepatide has also been investigated for the management of obesity in individuals without T2DM. Dr. Neeta Deshpande, a renowned expert on Diabetes and Obesity, aids us in our understanding of obesity and associated Mx.

Obesity Pharmacotherapy: Now and Future

Consultant Diabetologist & Bariatric Physician | Belgaum Diabetes Centre, Belgaum

Dr. Neeta Deshpande

1

536

12.2K

4.6

Sessions Taken

747

4.6